Medartis Holding AG (MDRSF)
- Previous Close
77.96 - Open
84.10 - Bid --
- Ask --
- Day's Range
84.10 - 84.10 - 52 Week Range
77.96 - 84.10 - Volume
113 - Avg. Volume
1 - Market Cap (intraday)
1.14B - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
1,401.67 - EPS (TTM)
0.06 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.
www.medartis.comRecent News: MDRSF
Performance Overview: MDRSF
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDRSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDRSF
Valuation Measures
Market Cap
1.14B
Enterprise Value
1.14B
Trailing P/E
1.51k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.37
Price/Book (mrq)
4.03
Enterprise Value/Revenue
4.88
Enterprise Value/EBITDA
40.77
Financial Highlights
Profitability and Income Statement
Profit Margin
0.29%
Return on Assets (ttm)
2.11%
Return on Equity (ttm)
0.25%
Revenue (ttm)
212.01M
Net Income Avi to Common (ttm)
619k
Diluted EPS (ttm)
0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
25.2M
Total Debt/Equity (mrq)
10.74%
Levered Free Cash Flow (ttm)
16.7M
Research Analysis: MDRSF
Company Insights: MDRSF
MDRSF does not have Company Insights